CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 31, 2016	Jan. 31, 2015	Jan. 31, 2016	Jan. 31, 2015
Operating Expenses:
Research and development	$ 67,628	$ 222,384	$ 245,198	$ 630,680
General and administrative (Note 4)	89,904	612,763	1,229,913	1,112,936
Total Operating Expenses	157,532	835,147	1,475,111	1,743,616
Operating Loss	(157,532)	(835,147)	(1,475,111)	(1,743,616)
Other Income/(Expense):
Interest income		2		11
Interest expense	(102,187)	(85,468)	(199,910)	(167,202)
Change in fair value of derivative liabilities (Note 8)	212,329	408,697	(103,634)	1,120,675
Gain on extinguishment of debt (Note 4)				(327,839)
Net (loss) / Income	$ (47,390)	$ (511,916)	$ (1,778,655)	$ (462,293)
Net (Loss) Income per Common Share (Note 6) - Basic			$ (0.002)	$ 0.0001
Net (Loss) Income per Common Share - Diluted			$ (0.002)	$ 0.0001
Basic Shares Used to Compute (Loss) / Income per Share (Note 6)	870,325,348	789,848,649	860,225,829	784,906,679
Diluted Shares Used to Compute (Loss) / Income per Share (Note 6)	870,555,584	520,661,184	560,225,829	784,906,679
Other Comprehensive (Loss) / Income
Net (loss) / Income	$ (47,390)	$ (511,916)	$ (1,778,655)	$ (462,293)
Change in foreign currency translation adjustments	(2,152)	27,718	(5,087)	31,235
Comprehensive (Loss) / Income	$ (49,542)	$ (484,198)	$ (1,783,742)	$ (431,058)